Iraqi Kurd Farmers Battle Drought as Lake Dukan Retreats

Dukan Dam and reservoir in Iraqi Kurdistan AHMAD AL-RUBAYE AFP
Dukan Dam and reservoir in Iraqi Kurdistan AHMAD AL-RUBAYE AFP
TT

Iraqi Kurd Farmers Battle Drought as Lake Dukan Retreats

Dukan Dam and reservoir in Iraqi Kurdistan AHMAD AL-RUBAYE AFP
Dukan Dam and reservoir in Iraqi Kurdistan AHMAD AL-RUBAYE AFP

Farmers in Iraqi Kurdistan seeking to irrigate crops face seeing their economic lifeline slip away as the waters of Lake Dukan recede and dams upstream in Iran stem the flow.

Bapir Kalkani, who is also a trade unionist, farms near the picturesque lake but has seen marked changes over the past three years as Iraq suffers prolonged drought.

"There was water where I'm standing now" in 2019, the 56-year-old said. "It used to go three kilometers (two miles) further, but the level has retreated."

Sesame and beans are being grown on the plain under a blazing sun, adjacent to the lake which is fed by a Tigris tributary, the Lower Zab river which has its source in Iran.

The large artificial lake was created in the 1950s following construction of the Dukan dam, to supply irrigation and drinking water for the region, as well as to generate electricity, AFP reported.

But for several years both the lake and the river have been shrinking -- as have all of the rivers in Iraq.

The country is classified as one of the five nations most vulnerable to the effects of climate change and desertification.

Its water reserves have fallen by 60 percent compared with last year, the government says.

With rainfall becoming a rarity and after three successive years of drought, Iraq has been forced to halve the area it devotes to agriculture.

"If we hadn't had a little rain in late spring, there would have been no crops in Kurdistan this year," Kalkani said.

Farmers in the area used to dig shallow wells fed by the Dukan so they could irrigate their crops. But not any more.

"The wells have lost 70 percent of their water," he said.

Sesame farmer Shirko Aziz Ahmed had to dig a well several meters deep so he could access water and raise it using a diesel-powered pump.

"Sesame needs a lot of watering, so I'm going to have to dig even deeper as the water level goes down," he said.

Drought is not the only source of the farmer's water problems.

Iran has built several dams on the Lower Zab, notably the Kolsa barrage.

"The Kolsa dam has caused at least an 80 percent drop in the water levels" of the Lower Zab, said Banafsheh Keynoush of the Washington-based Middle East Institute.

She said Iran is going through one of the worst droughts in its history and has had to revise its irrigation policy.

"Iran is on a dam-building spree, and many of its dams are small," she told AFP.

The Dukan dam in Iraq has also been badly affected by the reduced river flow, said its director Kochar Jamal Tawfeeq.

"Now we have only 41 percent, below half of the capacity" of the dam, he said.

It supplies drinking water for "about three million people in Sulaymaniyah and Kirkuk", two major cities downstream, he said.

But at just 300 mm (less than 12 inches) of rainfall last year -- half the previous annual average -- the skies have not been generous. And Tawfeeq said 2022 is on track to mirror last year's figures.

"We are releasing 90 cubic meters per second," the director said. "When the reservoir is full, we release 200 to 250."

Tawfeeq said farmers were being told "not to grow crops that need too much water".

He said Baghdad had sent teams to Iran to discuss the reduced flow of the Lower Zab river, but "there's no cooperation from the Iranians".

Iran contends its river flow contribution into the Tigris and Euphrates basin is only about six percent, according to Keynoush.

"What Iran is trying to say is: 'The Euphrates and Tigris problems you have are really between you and Turkey'," where the two main rivers have their sources, she added.

But Iraq itself is not above criticism, said Azzam Alwash, founder of the Nature Iraq non-government organization and presidential adviser.

Iraqi Kurdistan in the north plans to construct new dams but the projects lack any coordination with Baghdad, Alwash said.

Downstream, in central and south Iraq, the situation is being exasperated by a lack of modernization of water resources and could result in disaster, he warned.



Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”